Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 2, 2010, Pages 512-523

  Sanchez Mora C ^a   Ribases M ^a   Ramos Quiroga, J A ^a,b   Casas, M ^a,b   Bosch, R ^a   Boreatti Hummer A ^c   Heine, M ^c   Jacob, C P ^c   Lesch, K P ^c   Fasmer, O B ^d,e   Knappskog, P M ^d,e   Kooij, J J Sandra ^f   Kan, C ^g   Buitelaar, J K ^g   Mick, E ^h   Asherson, P ⁱ   Faraone, S V ^j   Franke, B ^g   Johansson, S ^d,e   Haavik, J ^d,e   Reif, A ^c   Bayes M ^k,l,m   Cormand, B ^n,o   more..

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

^f Program Adult ADHD   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^k CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^l CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^m Centro Nacional de Genotipado CeGen   (Spain)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

^o CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

more..

Author keywords

Adult ADHD; Attention deficit hyperactivity disorder; BDNF; Case control association study; Meta analysis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ADULTHOOD; ARTICLE; ATTENTION DEFICIT DISORDER; COMORBIDITY; CONTROLLED STUDY; EUROPE; FEMALE; GENDER; GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; EUROPE; FEMALE; GENETICS, POPULATION; GENOTYPE; HUMANS; MALE; MENTAL DISORDERS; METHIONINE; MODELS, GENETIC; MODELS, NEUROLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; SEX FACTORS; VALINE;

ANIMALIA;

EID: 77349112718     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31008     Document Type: Article

References (55)

1. Anney RJ, Hawi Z, Sheehan K, Mulligan A, Pinto C, Brookes KJ,Xu X, Zhou K, Franke B, Buitelaar J, et al. 2008a. Parent of origin effects in attention/ deficit hyperactivity disorder [ADHD]: Analysis of data from the international multicenterADHDgenetics [IMAGE] program.AmJ Med Genet Part B 147B(8):1495-1495.
2. Anney RJ, Lasky-Su J, O'Dushlaine C, Kenny E, Neale BM, Mulligan A, Franke B, Zhou K, Chen W, Christiansen H, et al. 2008b. Conduct disorder andADHD:Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet Part B 147B(8):1369-1378.
3. Bekker EM, Overtoom CC, Kooij JJ, Buitelaar JK, VerbatenMN,Kenemans JL. 2005. Disentangling deficits in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 62(10):1129-1136.
4. Brookes K, Xu X, Chen W, Zhou K, Neale B, Lowe N, Anney R, Franke B, Gill M, Ebstein R, et al. 2006. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: Association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry 11(10): 934-953.
5. Chase T, Carrey N, Soo E, Wilkinson M. 2007. Methylphenidate regulates activity regulated cytoskeletal associated but not brain-derived neurotrophic factor gene expression in the developing rat striatum. Neuroscience 144(3):969-984.
6. Chourbaji S, Hellweg R, Brandis D, Zorner B, Zacher C, Lang UE, Henn FA, Hortnagl H, Gass P. 2004. Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121(1-2):28-36.
7. Comings DE, Gade-Andavolu R, Gonzalez N,WuS,Muhleman D, Blake H, Dietz G, Saucier G, MacMurray JP. 2000. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: Multivariate regression analysis of 20 genes. Clin Genet 57(3):178-196.
8. Conner AC, Kissling C, Hodges E, Hunnerkopf R, Clement RM, Dudley E, Freitag CM, Rosler M, Retz W, Thome J. 2008. Neurotrophic factorrelated gene polymorphisms and adult attention deficit hyperactivity disorder [ADHD] score in a high-risk male population.AmJ Med Genet Part B 147B(8):1476-1480.
9. Duncan LE, Hutchison KE, Carey G, Craighead WE. 2009. Variation in brain-derived neurotrophic factor [BDNF] gene is associated with symptoms of depression. J Affect Disord 115(1-2):215-219.
10. Egan MF,Kojima M,Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2):257-269.
11. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. 2005. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11):1313-1323.
12. Fleiss J. 1981. Statistical methods for rates and proportions. 2nd edition. New York: Wiley.
13. Franke B, Hoogman M, Arias Vasquez A, Heister JG, Savelkoul PJ, Naber M, Scheffer H, Kiemeney LA, Kan CC, Kooij JJ, et al. 2008. Association of the dopamine transporter [SLC6A3/DAT1] gene 9-6 haplotype with adult ADHD. Am J Med Genet Part B 147B(8): 1576-1579.
14. Friedel S, Horro FF, Wermter AK, Geller F, Dempfle A, Reichwald K, Smidt J, Bronner G, Konrad K, Herpertz-Dahlmann B, et al. 2005. Mutation screen of the brain derived neurotrophic factor gene [BDNF]: Identifi-cation of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. Am J Med Genet Part B 132B(1):96-99.
15. Gonzalez JR, Armengol L, Sole X,Guino E, Mercader JM, Estivill X,Moreno V. 2007. SNPassoc: An R package to perform whole genome association studies. Bioinformatics 23(5):644-645.
16. Gratacòs M, González JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. 2007. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: Meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry 61(7):911-922.
17. Green EK, Raybould R, Macgregor S, Hyde S, Young AH,O'Donovan MC, Owen MJ, Kirov G, Jones L, Jones I, et al. 2006. Genetic variation of brainderived neurotrophic factor [BDNF] in bipolar disorder: Case-control study of over 3000 individuals from the UK. Br J Psychiatry 188:21-25.
18. Jacob CP, Romanos J, Dempfle A, Heine M, Windemuth-Kieselbach C, Kruse A, Reif A, Walitza S, Romanos M, Strobel A, et al. 2007. Comorbidity of adult attention-deficit/hyperactivity disorder with focus on personality traits and related disorders in a tertiary referral center. Eur Arch Psychiatry Clin Neurosci 257(6):309-317.
19. Johansson S, Halleland H, Halmoy A, Jacobsen KK, Landaas ET, Dramsdahl M, Fasmer OB, Bergsholm P, Lundervold AJ, Gillberg C, et al. 2008. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet Part B 147B(8): 1470-1475.
20. Kent L, Green E, Hawi Z, Kirley A, Dudbridge F, Lowe N, Raybould R, Langley K, Bray N, Fitzgerald M, et al. 2005. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor [BDNF] gene with susceptibility to ADHD. Mol Psychiatry 10(10):939-943.
21. Kernie SG, Liebl DJ, Parada LF. 2000. BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19(6):1290-1300.
22. Kim JW, Waldman ID, Faraone SV, Biederman J, Doyle AE, Purcell S, Arbeitman L, Fagerness J, Sklar P, Smoller JW. 2007. Investigation of parent-of-origin effects in ADHDcandidate genes.AmJ Med Genet Part B 144B(6):776-780.
23. Kobayashi S, Ogren SO, Ebendal T, Olson L. 1997. Intraventricular injection of NGF, but not BDNF, induces rapid motor activation that is inhibited by nicotinic receptor antagonists. Exp Brain Res 116(2): 315-325.
24. Kooij JJ, Buitelaar JK, van den Oord EJ, Furer JW, Rijnders CA, Hodiamont PP. 2005. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychol Med 35(6):817-827.
25. Laird NM, Mosteller F. 1990. Some statistical methods for combining experimental results. Int J Technol Assess Health Care 6(1):5-30.
26. Lang UE, Hellweg R, Sander T, Gallinat J. 2009. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 142: 120-122.
27. Lanktree M, Squassina A, Krinsky M, Strauss J, Jain U, Macciardi F, Kennedy JL, Muglia P. 2008. Association study of brain-derived neurotrophic factor [BDNF] and LIN-7 homolog [LIN-7] genes with adult attention-deficit/ hyperactivity disorder. Am J Med Genet Part B 147B(6):945-951.
28. Lasky-Su J, Anney RJ, Neale BM, Franke B, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, et al. 2008a. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B(8):1355-1358.
29. Lasky-Su J, Neale BM, Franke B, Anney RJ, Zhou K, Maller JB, Vasquez AA, Chen W, Asherson P, Buitelaar J, et al. 2008b. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am J Med Genet Part B 147B(8):1345-1354.
30. Lau J, Ioannidis JP, Schmid CH. 1997. Quantitative synthesis in systematic reviews. Ann Intern Med 127:820-826.
31. Lee J, Laurin N, Crosbie J, Ickowicz A, Pathare T, Malone M, Tannock R, Kennedy JL, Schachar R, Barr CL. 2007. Association study of the brainderived neurotropic factor [BDNF] gene in attention deficit hyperactivity disorder. Am J Med Genet Part B 144B(8):976-981.
32. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT, Craig DW, Romanos J, Heine M, Meyer J, et al. 2008. Molecular genetics of adult ADHD: Converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115(11): 1573-1585.
33. Linnarsson S, Bjorklund A, Ernfors P. 1997. Learning deficit in BDNF mutant mice. Eur J Neurosci 9(12):2581-2587.
34. Mantel N, Haenszel W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719-748.
35. Martin-Iverson MT,Todd KG, Altar CA. 1994. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine. J Neurosci 14:[3 Pt 1]: 1262-1270.
36. Meredith GE, Callen S, Scheuer DA. 2002. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 949(1-2):218-227.
37. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215.
38. Monteggia LM, Luikart B, Barrot M, Theobold D, Malkovska I, Nef S, Parada LF, Nestler EJ. 2007. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry 61(2):187-1897.
39. Neale BM, Lasky-Su J, Anney R, Franke B, Zhou K, Maller JB, Vasquez AA, Asherson P, Chen W, Banaschewski T, et al. 2008. Genome-wide association scan of attention deficit hyperactivity disorder. Am J Med Genet Part B 147B(8):1337-1344.
40. Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: Evidence from a family-based association study.Am J Hum Genet 71(3):651-655.
41. Oades RD, Lasky-Su J, Christiansen H, Faraone SV, Sonuga-Barke EJ, Banaschewski T, Chen W, Anney RJ, Buitelaar JK, Ebstein RP, et al. 2008. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/ hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav Brain Funct 4:48.
42. Ramos-Quiroga JA, Bosch R, Castells X, Valero S, Nogueira M, Gómez N, Yelmo S, Ferrer M, Martínez Y, Casas M. 2008. Effect of switching drug formulations from immediate-release to extended-release OROS methylphenidate: A chart review of Spanish adults with attention-deficit hyperactivity disorder. CNS Drugs 22(7):603-611.
43. Ribasés M, Hervás A, Ramos-Quiroga JA, Bosch R, Bielsa A, Gastaminza X, Fernández-Anguiano M, Nogueira M, Gómez-Barros N, Valero S, et al. 2008. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol Psychiatry 63(10):935-945.
44. Ribasés M, Ramos-Quiroga JA, Hervás A, Bosch R, Bielsa A, Gastaminza X, Artigas J, Rodríguez-Ben S, Estivill S, Casas M, et al. 2009. Exploration of 19 serotoninergic candidate genes in adults and children with attentiondeficit/ hyperactivity disorder identifies association for 5HT2A,DDCand MAOB. Mol Psychiatry 14(1):71-85.
45. Rios M, Fan G, Fekete C, Kelly J, Bates B, Kuehn R, Lechan RM, Jaenisch R. 2001. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15(10):1748-1757.
46. Schimmelmann BG, Friedel S, Dempfle A, Warnke A, Lesch KP, Walitza S, Renner TJ, Romanos M, Herpertz-Dahlmann B, Linder M, et al. 2007.No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene [BDNF] in ADHD. J Neural Transm 114(4):523-526.
47. Shimizu E, Hashimoto K, Iyo M. 2004. Ethnic difference of the BDNF 196G/A [val66met] polymorphism frequencies: The possibility to explain ethnic mental traits. Am J Med Genet Part B 126B(1):122-123.
48. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, et al. 2002. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 7(6):579-593.
49. Sonuga-Barke EJ, Lasky-Su J, Neale BM, Oades R, Chen W, Franke B, Buitelaar J, Banaschewski T, Ebstein R, Gill M, et al. 2008. Does parental expressed emotion moderate genetic effects in ADHD? An exploration using a genome wide association scan. Am J Med Genet Part B 147B(8):1359-1368.
50. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, Lambert SM, Wu PP, Wang Y, Spoonde AY, Koehler RT, et al. 2005. The SNPlex genotyping system:Aflexible and scalable platform for SNP genotyping. J Biomol Tech 16(4):398-406.
51. Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vasquez A, Buitelaar JK, Franke B. 2008. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: Effects of gender and ethnicity. Mol Psychiatry. doi: 10.1038/mp.2008. 109.
52. Whitehead A. 2002. Dealing with heterogeneity. Meta-analysis of controlled clinical trials. Chicester: Wiley. pp. 151-174.
53. Xu X, Mill J, Zhou K, Brookes K, Chen CK, Asherson P. 2007. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am J Med Genet Part B 144B(1):83-86.
54. Yang J, Siao CJ, Nagappan G, Marinic T, Jing D, McGrath K, Chen ZY, Mark W, Tessarollo L, Lee FS, et al. 2009. Neuronal release of proBDNF. Nat Neurosci 12(2):113-115.
55. Zintzaras E, Hadjigeorgiou GM. 2004. Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: A meta-analysis. J Hum Genet 49:474-481.